[The effect of topical administration of prostaglandin E2 on chemotherapy-associated oral mucosal lesions of the patients with hematological malignancies].
Ueda
E
E
Kitani
T
T
Masaoka
T
T
Horiuchi
A
A
Yonezawa
T
T
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015232:Dinoprostone; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced / Q000188:drug therapy*; D009061:Mouth Mucosa; D011458:Prostaglandins E / Q000008:administration & dosage*; D014456:Ulcer / Q000139:chemically induced / Q000188:drug therapy*
D000970:Antineoplastic Agents; D011458:Prostaglandins E; D015232:Dinoprostone